Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
540 participants
INTERVENTIONAL
2002-09-30
2006-07-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Screening for Atrial Fibrillation in Native AmeRicans Using iPhone ECG
NCT03740477
Efficacy of Different Ablation Strategies for Controlling Atrial Fibrillation
NCT00379301
Substrate Guided Ablation Therapy for Atrial Fibrillation
NCT04657978
Baseline Atrial Fibrosis Predicts Risk for Post-operative Atrial Fibrillation in Patients Undergoing Cardiac Surgery
NCT05014802
Secondary Prevention of Atrial Fibrilation
NCT03259893
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pacing Algorithms
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects who have experienced at least two episodes of rapid heart beats three months prior to enrollment.
Exclusion Criteria
* Subjects with atrial fibrillation due to reversible cause, (e.g. thyroid disease, pericarditis, post-surgery, alcohol abuse).
* Subjects with a history of one or more cardioversions (changing an abnormal heart rhythm into a normal one by either using medication or by the application of an electric shock) six months prior to enrollment.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medtronic Cardiac Ablation Solutions
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Not Required For IDE Studies
Role:
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Yuma, Arizona, United States
Fayetteville, Arkansas, United States
Fort Smith, Arkansas, United States
Bakersfield, California, United States
Berkeley, California, United States
Los Angeles, California, United States
Aurora, Colorado, United States
Stamford, Connecticut, United States
Clearwater, Florida, United States
Daytona Beach, Florida, United States
Ormond Beach, Florida, United States
Tampa, Florida, United States
Atlanta, Georgia, United States
Chicago, Illinois, United States
Lombard, Illinois, United States
Springfield, Illinois, United States
Shreveport, Louisiana, United States
Brighton, Massachusetts, United States
Lansing, Michigan, United States
Saint Paul, Minnesota, United States
Paterson, New Jersey, United States
Ridgewood, New Jersey, United States
East Syracuse, New York, United States
Rochester, New York, United States
Syracuse, New York, United States
Cincinnati, Ohio, United States
Cleveland, Ohio, United States
Columbus, Ohio, United States
Elyria, Ohio, United States
Pittsburgh, Pennsylvania, United States
Charleston, South Carolina, United States
Nashville, Tennessee, United States
Dallas, Texas, United States
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Gold MR, Hoffmann E; SAFARI Investigators. Rationale and design of a randomized clinical trial to assess the role of overdrive and triggered prevention pacing therapies in reducing atrial fibrillation: the Study of Atrial Fibrillation Reduction (SAFARI). Am Heart J. 2006 Aug;152(2):231-6. doi: 10.1016/j.ahj.2005.11.012.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
190
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.